Overactive Bladder - Results from #1840

Comparison of diary-derived bladder and sleep measurements across OAB individuals, primary insomniacs, and healthy control - Abstract August 17, 2012

Sacral neuromodulation and refractory overactive bladder: An emerging tool for an old problem - Abstract August 16, 2012

The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial/ethnic group and age: Results from OAB-POLL - Abstract August 15, 2012

How do urodynamics findings influence the treatment of the typical patient with overactive bladder? - Abstract August 14, 2012

Use of near infrared spectroscopy as an alternative to videourodynamics to detect detrusor overactivity in women with the overactive bladder syndrome - Abstract August 13, 2012

The incidence and etiology of overactive bladder in patients after cerebrovascular accident - Abstract August 11, 2012

Dose and aging effect on patients reported treatment benefit switching from the first overactive bladder therapy with tolterodine ER to fesoterodine: Post-hoc analysis from an observational and retrospective study - Abstract August 9, 2012

Does conservative management really benefit patients with OAB? - Abstract August 8, 2012

The efficacy and safety of solifenacin in patients with overactive bladder syndrome - Abstract August 8, 2012

Can modeled analysis of urodynamic recordings help to demonstrate the nervous control of the bladder and urethra during micturition? - Abstract August 7, 2012

Managing patients with ‘wet’ overactive bladder: results of pooled studies show efficacy of darifenacin as measured by ‘dry days’ - Abstract August 7, 2012

Comparison of videocystourethrography and ambulatory urodynamic monitoring in identifying the causes of overactive bladder symptoms - Abstract August 7, 2012

Psychometric properties of the Korean version of the overactive bladder questionnaire (OAB-q) in a Korean population - Abstract August 6, 2012

The effects of posterior tibial nerve stimulation on refractory overactive bladder syndrome and bladder circulation - Abstract August 3, 2012

Current state of diagnostics and treatment of overactive bladder in the Czech Republic - Five years ago and today - Abstract August 2, 2012

Prevalence and risk factors associated with overactive bladder - Abstract August 2, 2012

Lower urinary tract management in patients with neurological disease - Abstract August 2, 2012

An overview on mixed action drugs for the treatment of overactive bladder and detrusor overactivity - Abstract August 1, 2012

Higher glycosylated hemoglobin levels increase the risk of overactive bladder syndrome in patients with type 2 diabetes mellitus - Abstract August 1, 2012

An evaluation of patient and physician satisfaction with controlled-release oxybutynin 15 mg as a one-step daily dose in elderly and non-elderly patients with overactive bladder: Results of the STOP study - Abstract July 30, 2012

Page 93 of 108

SUFU MyBladder app